SEC Form 4 · accession 0001127602-15-010516
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul A Mahon
Officer — EVP & General Counsel
Period of report
Mar 5, 2015
Accepted (ET)
Mar 6, 2015 · 6:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 5, 2015 | M | 6,000 | $33.14 | A | 41,054 | D | |
| Common Stock | Mar 5, 2015 | S | 6,000 | $161.36 | D | 35,054 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking AwardF3,F2 | $33.14 | Mar 5, 2015 | M | 6,000 | D | Mar 13, 2010 | Mar 13, 2019 | Common Stock | 6,000 | 40,750 | D |
Explanation of responses
- F1Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F3Includes 222 shares acquired under the United Therapeutics Corporation Employee Stock Purchase Plan on March 4, 2015.